NCT03913195 Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injection Status COMPLETED Phase PHASE3
NCT03875209 10E8.4/iMab Bispecific Antibody in HIV-uninfected and HIV-infected Adults Status COMPLETED Phase PHASE1
NCT03837756 Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV Status COMPLETED Phase PHASE2
NCT03837015 Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women Status COMPLETED Phase PHASE1
NCT03834909 Pre-Exposure Prophylaxis Dosing in Pregnancy to Optimize HIV Prevention (PREP-P) Status WITHDRAWN Phase PHASE1
NCT03825536 Effect of Methamphetamine on Residual Latent HIV Disease Study Status COMPLETED Phase PHASE4
NCT03816137 Modelling the Interaction Between Rationally-designed Synthetic Model Viral Protein Immunogens Status COMPLETED Phase PHASE1
NCT03813979 Pharmacokinetics of Single-dose Dolutegravir in HIV-seronegative Subjects With Severe Hepatic Impairment Compared to Matched Controls. Status WITHDRAWN Phase PHASE4
NCT03757117 Gender-Affirmative Transgender Care to Improve the HIV Treatment Cascade Status COMPLETED Phase PHASE4
NCT03729778 Impact of HIV-1 and Aging on Mucosal Vaccine Responses Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT03729752 PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01) Status RECRUITING Phase PHASE1
NCT03719664 Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects Status UNKNOWN Phase PHASE2
NCT03709355 Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs Status COMPLETED Phase PHASE1
NCT03706950 Post-approval Observational Study of Elpida® in the First Line Therapy for HIV-1 Infected Patients With Background Standard ART Status UNKNOWN Phase N/A